Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
University of Wisconsin-Madison
mi
from
Madison, WI
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Limb Girdle Muscular Dystrophy (LGMD) Natural History
Longitudinal Assessment and Genetic Understanding of Limb-Girdle Muscular Dystrophy
Status: Enrolling
Updated:  7/18/2017
Carolinas Medical Center - Pediatrics
mi
from
Charlotte, NC
Limb Girdle Muscular Dystrophy (LGMD) Natural History
Longitudinal Assessment and Genetic Understanding of Limb-Girdle Muscular Dystrophy
Status: Enrolling
Updated: 7/18/2017
Carolinas Medical Center - Pediatrics
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Banner Sun Health Research Institute
mi
from
Sun City, AZ
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
The University of California, San Diego
mi
from
La Jolla, CA
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Mount Sinai Medical Center of Florida
mi
from
Miami Beach, FL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Mount Sinai Medical Center of Florida
mi
from
Miami Beach, FL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Galiz Research
mi
from
Miami Springs, FL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Galiz Research
mi
from
Miami Springs, FL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Compass Research LLC
mi
from
Orlando, FL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Physicians Care Clinical Research
mi
from
Sarasota, FL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Physicians Care Clinical Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Rush University Medical Center
mi
from
Chicago, IL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Southern Illinois University School of Medicine
mi
from
Springfield, IL
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Biomedical Research Foundation
mi
from
Shreveport, LA
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Biomedical Research Foundation
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Las Vegas Radiology
mi
from
Las Vegas, NV
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Las Vegas Radiology
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Wake Forest Baptist Health-Gerontology
mi
from
Winston-Salem, NC
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Wake Forest Baptist Health-Gerontology
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Valley Medical Center
mi
from
Centerville, OH
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Valley Medical Center
mi
from
Centerville, OH
Click here to add this to my saved trials
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated:  7/25/2017
Albert Einstein College of Medicine
mi
from
The Bronx, NY
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Status: Enrolling
Updated: 7/25/2017
Albert Einstein College of Medicine
mi
from
The Bronx, NY
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
University of Alabama
mi
from
Birmingham, AL
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
Mayo Clinic
mi
from
Scottsdale, AZ
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
University of California at Los Angeles - UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
UCSD Department of Neurosciences
mi
from
San Diego, CA
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
UCSD Department of Neurosciences
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
University of California at San Francisco
mi
from
San Francisco, CA
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
University of Florida College of Medicine
mi
from
Gainesville, FL
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
Mayo Clinic
mi
from
Jacksonville, FL
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
The Mayo Clinic
mi
from
Rochester, MN
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
Columbia University
mi
from
New York, NY
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
Texas Health Presbyterian Dallas
mi
from
Dallas, TX
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
Texas Health Presbyterian Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated:  7/25/2017
Indiana University Medical Center
mi
from
Indianapolis, IN
Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
Status: Enrolling
Updated: 7/25/2017
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Coagulation in Multiple Sclerosis
A Cross-Sectional Study of Coagulation in Multiple Sclerosis
Status: Enrolling
Updated:  7/27/2017
Bastyr University Clinical Research Center
mi
from
Kenmore, WA
Evaluation of Coagulation in Multiple Sclerosis
A Cross-Sectional Study of Coagulation in Multiple Sclerosis
Status: Enrolling
Updated: 7/27/2017
Bastyr University Clinical Research Center
mi
from
Kenmore, WA
Click here to add this to my saved trials
Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1
Phase I Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 Delivering AVXS-101
Status: Enrolling
Updated:  8/1/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1
Phase I Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 Delivering AVXS-101
Status: Enrolling
Updated: 8/1/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection
A Prospective Study for the Detection of Nephrogenic Systemic Fibrosis in Patients With Renal Impairment Undergoing Gadoversetamide-enhanced Magnetic Resonance Imaging
Status: Enrolling
Updated:  8/1/2017
Radiology Consultants, Inc.
mi
from
Youngstown, OH
Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection
A Prospective Study for the Detection of Nephrogenic Systemic Fibrosis in Patients With Renal Impairment Undergoing Gadoversetamide-enhanced Magnetic Resonance Imaging
Status: Enrolling
Updated: 8/1/2017
Radiology Consultants, Inc.
mi
from
Youngstown, OH
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Good Samaritan Hospital
mi
from
Los Angeles, CA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Good Samaritan Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
University of California, Davis Medical Center
mi
from
Sacramento, CA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Stanford Univ Med Ctr
mi
from
Stanford, CA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Medical Center of Aurora
mi
from
Aurora, CO
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Medical Center of Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Penrose Saint Francis Health Services
mi
from
Colorado Springs, CO
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Penrose Saint Francis Health Services
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
The Hartford Hospital
mi
from
Hartford, CT
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
George Washington University Medical Faculty Associates
mi
from
Washington, D.C.,
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
George Washington University Medical Faculty Associates
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
University of Miami Hospital
mi
from
Miami, FL
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Florida Hospital
mi
from
Orlando, FL
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Florida Heart Rhythm-University of South Florida College of Medicine
mi
from
Tampa, FL
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Florida Heart Rhythm-University of South Florida College of Medicine
mi
from
Tampa, FL
Click here to add this to my saved trials
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated:  8/2/2017
Augusta University
mi
from
Augusta, GA
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Status: Enrolling
Updated: 8/2/2017
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials